Market Tracker

10/23 5:07am ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

88.76
Data as of Oct 22
 -0.16 / -0.18%
Today’s Change
47.03
Today|||52-Week Range
112.57
+38.04%
Year-to-Date

Today’s Trading

Previous close88.92
Today’s open89.00
Day’s range-- - --
Volume555,501
Average volume (3 months)696,329
Market cap$6.8B
Dividend yield--
Data as of 10/22/2014

Growth & Valuation

Earnings growth (last year)+31.28%
Earnings growth (this year)-268.14%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-29.31%
P/E ratioNM
Price/Sales83.91
Price/Book20.97

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...+0.05+0.09%
CBSTCubist Pharmaceutica...+2.75+4.14%
ISISIsis Pharmaceuticals...-0.64-1.56%
ICLRICON PLC+0.14+0.25%
Data as of 10/22/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)-$0.63
Annual revenue (last year)$47.2M
Annual profit (last year)-$89.2M
Net profit margin-189.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts